Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02429167 · ClinicalTrials.gov registry record · NA
Study of Safety and Effectiveness of PoNS Device to Treat Chronic Balance Deficit Due to Traumatic Brain Injury (TBI)
A NA study, sponsored by Helius Medical.
- Completed
- Registry status
- NA
- Development phase
- 122
- Enrollment target
NCT02429167 is a NA study that has completed, run by Helius Medical. The registered enrollment target is 122 participants.
The verdict
NCT02429167, a NA study, has completed, sponsored by Helius Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 122 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if clinic and home training with a study device will improve a balance deficit. The study device is called Portable Neuromodulation Stimulator (PoNS). The study device will be placed on the tongue to deliver nerve stimulation. The study is testing if use of the study device in conjunction with physical therapy will improve balance and gait in patients suffering from a TBI. The effects of using the device and undergoing therapy will be measured using standardized tests of movement control, gait, headache and other TBI symptoms.
Interventions
- DEVICE Cranial nerve non-invasive neuromodulation via PoNS device
- DEVICE Sham PoNS device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2015-08 |
| Est. Completion | 2017-08-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02429167
The ClinicalTrials.gov registry entry for NCT02429167 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Helius Medical, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cranial nerve non-invasive neuromodulation via PoNS device is the first listed.
NCT02429167 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02429167 about?
NCT02429167 is a clinical study titled "Study of Safety and Effectiveness of PoNS Device to Treat Chronic Balance Deficit Due to Traumatic Brain Injury (TBI)". The purpose of this study is to determine if clinic and home training with a study device will improve a balance deficit. The study device is called Portable Neuromodulation Stimulator (PoNS). The study device will be placed on the tongue to deliver nerve stimulation. The study is testing if use of ...
What is the current status of trial NCT02429167?
This trial is currently completed. It is a NA study. The enrollment target is 122 participants. The study started on 2015-08. Estimated completion is 2017-08-18.
What interventions are being tested in trial NCT02429167?
The interventions under investigation include: Cranial nerve non-invasive neuromodulation via PoNS device (DEVICE), Sham PoNS device (DEVICE).
Who is sponsoring clinical trial NCT02429167?
This trial is sponsored by Helius Medical, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.